Concepedia

Dennis Meletiche

DM

Statistics

Publications

10

Citations

521

H-Index

10

Active since

1999

Affiliations

Ono Pharmaceutical (United States)(Current)

Thomas Jefferson University

Analysis Group (United States)

Dennis Meletiche is an author at Ono Pharmaceutical (United States) specializing in pharmacy, multiple sclerosis, and neurology.

Publications per year

1999–2021

10

Publications

10

Quality‐of‐Life Differences Between Patients With Episodic and Transformed Migraine

Dennis Meletiche, Jennifer H. Lofland, William B. Young · Headache The Journal of Head and Face Pain · 2001 · 165 citations

, , +11

Comparing the Cost-Effectiveness of Disease-Modifying Drugs for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis

Lawrence Goldberg, Natalie C. Edwards, Contessa Fincher et al. · Journal of Managed Care Pharmacy · 2009 · 106 citations · Full text

, , +10

The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US

Jasmina I. Ivanova, Howard G. Birnbaum, Seth Samuels et al. · PharmacoEconomics · 2009 · 75 citations

, , +11

Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders

Frank D. Gianfrancesco, Amy Grogg, Ramy Mahmoud et al. · Clinical Therapeutics · 2003 · 62 citations

, , +15

Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs

Howard G. Birnbaum, Jasmina I. Ivanova, Seth Samuels et al. · Current Medical Research and Opinion · 2009 · 32 citations

, , +16

1–5 of 10